This study used two transgenic mouse models of PCa and tumor samples from PCa patients with clinical data to evaluate the tissue expression pattern of proteoglycans of the syndecan family and SDCBP and its behavior during the process of tumor progression, patient biochemical recurrence, and survival. The gene discussed is SDCBP; the disease is neoplasm.